| abstract |
The present invention relates to a compound of formula (I): Wherein W is NR 1A or CR 1B R 1B ; Z is N or CH; R 1A is C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl or phenyl, wherein The cycloalkyl or phenyl group is optionally mono-, di- or tri-substituted with substituents independently selected from C 1 -C 3 alkyl, halo, amine and C 1 -C 3 alkoxy; R 1B is bonded to its attached carbon atom and forms a C 3 -C 6 cycloalkyl or heterocyclic group, wherein the cycloalkyl group is via C(=O)OR 1C , NHC(=O)OR 1C or NHS (=O) 2 R 1C substituted, and the heterocyclic group is via C(=O)R 1C , C(=O)OR 1C , S(=O) 2 R 1C , C(=O)NH 2 or C (=O)NR 1C R 1C′ substituted; n is 0, 1 or 2; n, q, R 1C , R 1C′ , R 2 and R 3 are as defined herein, and their use as inhibitors of RSV And related aspects. |